e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Stress responses and T-cell behaviour in the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The potential interaction of MARCKS-related peptide and diltiazem on acrolin-induced airway mucus hypersecretion in rats
Y. Shen, P. Chen, Z. P. Deng, T. Wang, F. Q. Wen, L. Chen, J. Q. Li, Y. L. Feng, S. F. Zhang, Y. Y. Nin, D. S. Liu, Y. J. Chen, X. M. Ou (Chengdu, China)
Source:
Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Session:
Stress responses and T-cell behaviour in the lung
Session type:
Thematic Poster Session
Number:
3890
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Shen, P. Chen, Z. P. Deng, T. Wang, F. Q. Wen, L. Chen, J. Q. Li, Y. L. Feng, S. F. Zhang, Y. Y. Nin, D. S. Liu, Y. J. Chen, X. M. Ou (Chengdu, China). The potential interaction of MARCKS-related peptide and diltiazem on acrolin-induced airway mucus hypersecretion in rats. Eur Respir J 2013; 42: Suppl. 57, 3890
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Allosteric inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) slows airway mucus transport in normal sheep
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
Cell adhesion molecules and cathelicidin in mice model of hypersensitivity pneumonitis
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Airway surface dehydration confers susceptibility to allergic airway inflammation in vivo
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Andrographolide restores steroid sensitivity to block LPS/IFN-γ-induced IL-27 and airway hyperresponsiveness in mice
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
LATE-BREAKING ABSTRACT: E-cigarette exposure induces pathological responses that result in lung tissue destruction and airway hyper reactivity in mice.
Source: International Congress 2014 – E-cigarettes in different populations
Year: 2014
LATE-BREAKING ABSTRACT: The involvement of serotonin in cigarette smoke-induced airway remodeling in mice
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
The role of the K
Ca
3.1 channel in the regulation of airway mucus hypersecretion in asthma
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
CXCR1 is dispensable for allergy-driven airway leukocyte recruitment in vivo
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
An integrated culture system for in vitro human airway modeling
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Lung inflammation: The role of alveolar macrophages
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Muscarinic M
3
receptors on structural cells regulate neutrophilic inflammation in mice
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
LATE-BREAKING ABSTRACT: MUC1 downregulation induces corticosteroid resistance in asthma’s in vitro and in vivo models
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept